Guerbet Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GUERBET
GUERBET has five approved drugs.
There are four US patents protecting GUERBET drugs.
There are eighty-seven patent family members on GUERBET drugs in twenty-eight countries and thirteen supplementary protection certificates in eleven countries.
Summary for Guerbet
| International Patents: | 87 |
| US Patents: | 4 |
| Tradenames: | 6 |
| Ingredients: | 5 |
| NDAs: | 5 |
| Drug Master File Entries: | 1 |
Drugs and US Patents for Guerbet
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Guerbet | ELUCIREM | gadopiclenol | SOLUTION;INTRAVENOUS | 216986-004 | Sep 21, 2022 | RX | Yes | Yes | 8,114,863 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Guerbet | ELUCIREM | gadopiclenol | SOLUTION;INTRAVENOUS | 216986-003 | Sep 21, 2022 | RX | Yes | Yes | 8,114,863 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Guerbet | ELUCIREM | gadopiclenol | SOLUTION;INTRAVENOUS | 216986-001 | Sep 21, 2022 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Guerbet | ELUCIREM | gadopiclenol | SOLUTION;INTRAVENOUS | 216986-006 | Sep 21, 2022 | RX | Yes | Yes | 11,590,246 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Guerbet | DOTAREM | gadoterate meglumine | SOLUTION;INTRAVENOUS | 204781-002 | Mar 20, 2013 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Guerbet
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | 4,094,966 | ⤷ Start Trial |
| Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | 4,014,986 | ⤷ Start Trial |
| Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | 4,065,554 | ⤷ Start Trial |
| Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | 4,065,553 | ⤷ Start Trial |
| Guerbet | OXILAN-300 | ioxilan | INJECTABLE;INJECTION | 020316-001 | Dec 21, 1995 | 4,954,348 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Guerbet Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2024178261 | ⤷ Start Trial |
| Singapore | 11202107779S | ⤷ Start Trial |
| Spain | 2938015 | ⤷ Start Trial |
| Mexico | 2021008651 | ⤷ Start Trial |
| Hungary | E060343 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Guerbet Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1931673 | C01931673/01 | Switzerland | ⤷ Start Trial | PRODUCT NAME: GADOPICLENOL; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 69037 21.12.2023 |
| 1931673 | 301259 | Netherlands | ⤷ Start Trial | PRODUCT NAME: GADOPICLENOL; REGISTRATION NO/DATE: EU/1/23/1772 20231208 |
| 1931673 | 24C1006 | France | ⤷ Start Trial | PRODUCT NAME: GADOPICLENOL; REGISTRATION NO/DATE: EU/1/23/1772 20231208 |
| 1931673 | 7/2024 | Austria | ⤷ Start Trial | PRODUCT NAME: GADOPICLENOL; REGISTRATION NO/DATE: EU/1/23/1772 (MITTEILUNG) 20231208 |
| 1931673 | 813 | Finland | ⤷ Start Trial | |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
